Publications by authors named "Yayan Zhang"

Claim this Profile
P
Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial.
Jean-Pascal Machiels, Yungan Tao, Lisa Licitra, Barbara Burtness, Makoto Tahara, Yayan Zhang

Lancet Oncol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Terrestrial dissolved organic matter inputs accompanied by dissolved oxygen depletion and declining pH exacerbate CO emissions from a major Chinese reservoir.
Ting Zhang, Lei Zhou, Yongqiang Zhou, Yunlin Zhang, Jinxin Guo, Yayan Zhang

Water Res· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LITESPARK-011: belzutifan plus lenvatinib vs cabozantinib in advanced renal cell carcinoma after anti-PD-1/PD-L1 therapy.
Robert J Motzer, Manuela Schmidinger, Masatoshi Eto, Cristina Suarez, Robert Figlin, Yayan Zhang

Future Oncol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab for myelodysplastic syndromes after failure of hypomethylating agents in the phase 1b KEYNOTE-013 study.
Guillermo Garcia-Manero, Vincent Ribrag, Yayan Zhang, Mohammed Farooqui, Patricia Marinello

Leuk Lymphoma· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting Drug-Drug Interactions Based on Integrated Similarity and Semi-Supervised Learning.
Cheng Yan, Guihua Duan, Yayan Zhang, Fang-Xiang Wu, Yi Pan

IEEE/ACM Trans Comput Biol Bioinform· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Further clinical interpretation and implications of KEYNOTE-048 findings - Authors' reply.
Barbara Burtness, Yayan Zhang, Kevin J Harrington, Danny Rischin

Lancet· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study.
Barbara Burtness, Kevin J Harrington, Richard Greil, Denis Soulières, Makoto Tahara, Yayan Zhang

Lancet· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and tolerability of pembrolizumab in patients with relapsed/refractory primary mediastinal large B-cell lymphoma.
Pier Luigi Zinzani, Vincent Ribrag, Craig H Moskowitz, Jean-Marie Michot, John Kuruvilla, Yayan Zhang

Blood· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Controllable growth of ZnO nanorod arrays with different densities and their photoelectric properties.
Shujie Wang, Chongshun Song, Ke Cheng, Shuxi Dai, Yayan Zhang

Nanoscale Res Lett· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis